发明名称 USE OF RECOMBINANT HUMAN UTEROGLOBIN IN TREATMENT OF FIBROTIC CONDITIONS
摘要 <p>Method for treatment of inflammatory and fibrotic conditions in vivo using pure rhUG is disclosed. Method for treating or preventing inflammatory or fibrotic conditions characterized by a deficiency of endogenous functional UG is also disclosed. Compositions containing pure rhUG, optionally also containing lung surfactant, and assay procedures for detection of UG-fibronectin complexes, are also provided.</p>
申请公布号 EP1023081(B1) 申请公布日期 2007.10.03
申请号 EP19980925036 申请日期 1998.05.28
申请人 CLARAGEN, INC.;NATIONAL INSTITUTE OF HEALTH 发明人 PILON, APRILE, L.;MUKHERJEE, ANIL, B.;ZHANG, ZHONGJIAN
分类号 A61K9/08;A61K38/17;A61K8/64;A61K8/96;A61K8/98;A61K9/12;A61K38/00;A61K45/00;A61P1/00;A61P1/04;A61P1/18;A61P3/10;A61P7/00;A61P9/00;A61P11/00;A61P11/06;A61P13/02;A61P13/08;A61P13/10;A61P13/12;A61P15/00;A61P15/02;A61P15/06;A61P15/08;A61P17/00;A61P17/02;A61P17/06;A61P19/00;A61P27/02;A61P29/00;A61P37/06;A61P37/08;A61P43/00;A61Q17/00;A61Q19/00;C07K14/47;C12N1/21;C12N15/85;G01N33/50 主分类号 A61K9/08
代理机构 代理人
主权项
地址